BOULDER, Colo., Sept. 14 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the Leerink Swann & Company Cancer Medicines on the
Horizon Conference on September 18 in New York City. The public is welcome
to participate in the conference through an audio webcast on the Array
Event: Leerink Swann & Company Cancer Medicines on the Horizon
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Monday, September 18, 2006
Time: 10:15 am Eastern Time
Location: Le Parker Meridien, New York City
Audio Webcast: www.arraybiopharma.com
Additionally, Array's President and Chief Scientific Officer, Kevin
Koch, Ph.D., will speak on an expert panel entitled "New Therapy" during
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat life threatening and debilitating diseases. Our proprietary
drug development pipeline is focused on the treatment of cancer and
inflammatory disease and includes clinical candidates that are designed to
regulate therapeutically important targets. In addition, leading
pharmaceutical and biotechnology companies collaborate with Array to
discover and develop drug candidates across a broad range of therapeutic
areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.